Zhou, Z., Yang, Y., Chen, S., & You, M. Cost-effectiveness analysis of first-line cadonilimab plus chemotherapy in HER2-negative advanced gastric or gastroesophageal junction adenocarcinoma. Frontiers Media S.A.
Chicago Style (17th ed.) CitationZhou, Zhifeng, Yanqing Yang, Shaofang Chen, and Maojin You. Cost-effectiveness Analysis of First-line Cadonilimab Plus Chemotherapy in HER2-negative Advanced Gastric or Gastroesophageal Junction Adenocarcinoma. Frontiers Media S.A.
MLA (9th ed.) CitationZhou, Zhifeng, et al. Cost-effectiveness Analysis of First-line Cadonilimab Plus Chemotherapy in HER2-negative Advanced Gastric or Gastroesophageal Junction Adenocarcinoma. Frontiers Media S.A.
Warning: These citations may not always be 100% accurate.